Sebastian Kreuz
Executive Director / Investment Manager (BI Venture Fund)
Ingelheim am Rhein, Rhineland-Palatinate, Germany
39 investmentsSebastian Kreuz is an Executive Director / Investment Manager (BI Venture Fund) based in Ingelheim am Rhein, Rhineland-Palatinate, Germany. Sebastian Kreuz has backed 39 companies, including Aignostics, T3 Pharmaceuticals and Dopavision. Investment focus areas include Health Care, Hospitals and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (39)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Aignostics | — | — | — | — |
| 2 | T3 Pharmaceuticals | — | — | — | — |
| 3 | Dopavision | — | — | — | — |
| 4 | Topas Therapeutics | — | — | — | — |
| 5 | Actym | — | — | — | — |
| 6 | eTheRNA immunotherapies | — | — | — | — |
| 7 | STAT-Dx | — | — | — | — |
| 8 | Rinri Therapeutics | — | — | — | — |
| 9 | Rigontec | — | — | — | — |
| 10 | Hookipa Pharma | — | — | — | — |
| 11 | Tacalyx | — | — | — | — |
| 12 | NBE-Therapeutics | — | — | — | — |
Showing 1–12 of 39
Page 1 of 4
Access Full Contact Information
Get Sebastian Kreuz's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required